Why more genes are being discussed
Genetic tests used to look at one or two genes at a time. Many now look at a panel of genes in a single test. That means more people are learning about genes they had never heard of, and results can be harder to make sense of without expert help.
PALB2 in brief
PALB2 works closely with BRCA2 inside cells, helping to repair damaged DNA. An inherited change in PALB2 is linked to a higher chance of breast cancer and, to a lesser extent, some other cancers. How much higher depends on the specific change and on family history, which is why a genetics professional looks at the whole picture rather than the gene name alone.
Other genes you may see on a report
- CHEK2 and ATM, generally linked to a moderate increase in breast cancer likelihood.
- TP53 and PTEN, rarer genes associated with wider family syndromes.
- RAD51C, RAD51D and BRIP1, mainly discussed in relation to ovarian health.
This list is not complete, and research keeps adding detail. Specialists use up-to-date guidance to decide what a result means for checks and options.
Understanding uncertain results
Sometimes a test finds a change that scientists cannot yet classify as harmful or harmless. This is called a variant of uncertain significance. Until it is better understood, specialists usually base their advice on family history, and the result may be reclassified as knowledge grows. It is worth asking how you will hear about any update.
Talking it through
- Ask what the result means for you, and what it might mean for your relatives.
- Ask which checks or options are suggested, and from what age.
- Ask for a written summary to keep and to share with family if you wish.
Results can also matter for relatives, who may choose to be tested for the same change once it is known in the family.